Active Investment Portfolio Cherrystone Angel Group has invested over 25 million dollars across diverse startups, indicating a strong focus on emerging innovations and early-stage ventures in technology and healthcare sectors, presenting opportunities for complementary services or products.

Recent Funding Movements The group's recent involvement in seed funding rounds, such as the 1.3 million dollar investment in Lenoss Medical, demonstrates ongoing interest in biomedical startups, offering potential collaboration or service opportunities in medical device and biotech markets.

Sustainable Market Presence With a solid revenue range between 10 to 25 million dollars and a history of multiple funding rounds, Cherrystone shows financial stability and growth potential, making it a reliable partner for technology and service providers targeting the venture capital ecosystem.

Strategic Focus Areas The company’s investments in health technology and biomedical startups highlight a strategic interest in innovative healthcare solutions, opening doorways for companies specializing in medtech, biotech, and healthcare IT to offer tailored solutions.

Market Networking Opportunities Being one of the premier angel groups in New England and New York with extensive participation in funding rounds suggests ample networking opportunities for B2B engagement, especially for firms looking to connect with early-stage financiers and co-investors in the innovation ecosystem.